Skip to main content

Neurocrine Biosciences Inc 10-Q for FY2024 Q2

Neurocrine Biosciences Inc (NBIX)

10-Q 2024-08-01 For: 2024-06-30
View Original
Added on April 04, 2026

About this 10-Q

Neurocrine Biosciences Inc filed this 10-Q on August 1, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$590.2M
up 30.4% from $452.7M a year earlier
Net income
$65M
down 31.9% from net income of $95.5M a year earlier
Diluted EPS
$0.63
down 33.7% from $0.95 a year earlier